Skip to content

Tolerance of the vNOTES Surgical Technique in Total Hysterectomy for Benign Lesion. Clinical Trial of Non-inferiority Compared to the Laparoscopic Technique.

Tolerance of the vNOTES Surgical Technique in Total Hysterectomy for Benign Lesion. Clinical Trial of Non-inferiority Compared to the Laparoscopic Technique.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05031182
Acronym
VLAP
Enrollment
145
Registered
2021-09-01
Start date
2021-10-11
Completion date
2025-02-25
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysterectomy, Laparoscopy, vNOTES

Brief summary

During a first consultation with an indication of total hysterectomy for a benign lesion, we will study the patient's eligibility. After explanations of the study and submission of the forms, the patient will benefit from a second consultation with the investigator to give her consent. The surgeon will randomize the patient using RedCap computer software. The patient will then be referred either to the vNOTES group or to the laparoscopy group. The surgery will be performed by surgeons called "expert" in one of the ways first. For this, it will be necessary to have performed at least 25 hysterectomies by laparoscopy or vNOTES. The surgery will take place using the usual techniques. Per and postoperative complications will be studied and noted up to six months postoperatively.

Interventions

PROCEDURELaparoscopy

The hysterectomy is performed by laparoscopy as described in the EMC.

PROCEDUREvNOTES

The hysterectomy is performed by vNOTES as described Dr BAEKELANDT and this team.

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult woman eligible for total hysterectomy for benign lesions with or without bilateral adnexectomy. * Able to give informed consent to participate in research. * Affiliation to a Social Security scheme.

Exclusion criteria

* Pregnant or breastfeeding women * Contraindication to the laparoscopic approach * Contraindication to first vNOTES, in particular: virginity, history of rectal surgery, rectovaginal endometriosis, high active genital infection * Indications for another concomitant surgical procedure (other than procedure on the appendix) * Indication of hysterectomy for malignant lesion. * Any concomitant pathology deemed incompatible with the study. * COVID not cured or SARS-COv2 positivity dating less than 3 days before surgery. * Adult patient protected, under guardianship or curatorship or legal safeguard * Refusal of participation.

Design outcomes

Primary

MeasureTime frameDescription
Complications per or post Operativeone month after surgeryAppearance of a per or post operative complication: bleeding, digestive or urinary sore or infection

Secondary

MeasureTime frameDescription
Measure of painUntil one monthQuantification of postoperative pain: 6 hours, 24 hours, day 2, 5, 7, 14 and at one month
Duration of operationone dayFrom skin opening to skin or vaginal closure
Assessment of quality of lifeSix monthRespond to SF-36 questionnaire to assess and compare quality of life before and after surgery
Assessment of satisfactionSix monthRespond to FSFI questionnaire to assess and compare sexuality before and after surgery
Duration of work stoppageone monthPatients will inquire if they needed to prolong the sick leave.

Countries

France

Contacts

PRINCIPAL_INVESTIGATORSandra CURINIER

University Hospital, Clermont-Ferrand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026